跳至主要内容
临床试验/ISRCTN16415327
ISRCTN16415327进行中(未招募)Unknown

Azithromycin use in labour to prevent maternal sepsis among pregnant women undergoing vaginal birth in Nigeria (AZIN-V): a cluster-randomised hybrid type-2 effectiveness implementation trial

niversity of Lagos0 个研究点目标入组 5,040 人开始时间: 2024年7月3日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
5,040

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Pregnant women with singleton or multiple pregnancies of at least 24+0 weeks GA in labour including those in the first stage with cervical dilatation of =7 cm or in the second stage of labour
  • 2. Admitted in labour to the participating health facilities for spontaneous or induced vaginal birth
  • 3. Women presenting with stillbirth will also be eligible since they are at risk of postpartum sepsis

排除标准

  • 1. Gestational age <24 weeks at screening
  • 2. Not admitted to the facility with a plan to deliver vaginally
  • 3. In preterm contraction and no immediate plan for delivery
  • 4. Has fever >38°C with no other explanation
  • 5. Has evidence of macrolide antibiotic use in the previous three days
  • 6. Known allergy to azithromycin or its excipients or other macrolides
  • 7. Known to have an arrhythmia or a known history of cardiomyopathy
  • 8. Planned caesarean delivery

研究者

发起方
niversity of Lagos

相似试验